Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hasenfuss

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Cardiovascular Research|October 9, 1998
Animal models of human cardiovascular disease, heart failure and hypertrophyG Hasenfuss
Der Internist|July 15, 2004
[AT(1) blocker for post-infarct therapy. VALIANT Study]G Hasenfuss
Cardiovascular Research|June 6, 1998
Alterations of calcium-regulatory proteins in heart failureG Hasenfuss
Circulation Research|October 31, 1998
Calcium pump overexpression and myocardial function. Implications for gene therapy of myocardial failureG Hasenfuss
Zeitschrift Fur Kardiologie|January 1, 1992
[New cardiotonic/inodilator agents: energetic aspects]G Hasenfuss
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1995
Cardiac changes in diabetesG Hasenfuss
Der Internist|November 5, 2004
[Acute cor pulmonale in pulmonary embolism. An important prognostic factor and a critical parameter for the choice of a therapeutic strategy]S Konstantinides, G Hasenfuss
British Heart Journal|August 1, 1994
Myocardial phenotype changes in heart failure: cellular and subcellular adaptations and their functional significanceG Hasenfuss, H Just
Circulation|November 14, 1997
International Gargellen ConferenceG Hasenfuss, H Just
Therapeutische Umschau. Revue Therapeutique|June 22, 2000
[Pathophysiological basis of heart failure]B Pieske, G Hasenfuss
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Cardiovascular Research|October 9, 1998
Animal models of human cardiovascular disease, heart failure and hypertrophyG Hasenfuss
Der Internist|July 15, 2004
[AT(1) blocker for post-infarct therapy. VALIANT Study]G Hasenfuss
Cardiovascular Research|June 6, 1998
Alterations of calcium-regulatory proteins in heart failureG Hasenfuss
Circulation Research|October 31, 1998
Calcium pump overexpression and myocardial function. Implications for gene therapy of myocardial failureG Hasenfuss
Zeitschrift Fur Kardiologie|January 1, 1992
[New cardiotonic/inodilator agents: energetic aspects]G Hasenfuss
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1995
Cardiac changes in diabetesG Hasenfuss
Der Internist|November 5, 2004
[Acute cor pulmonale in pulmonary embolism. An important prognostic factor and a critical parameter for the choice of a therapeutic strategy]S Konstantinides, G Hasenfuss
British Heart Journal|August 1, 1994
Myocardial phenotype changes in heart failure: cellular and subcellular adaptations and their functional significanceG Hasenfuss, H Just
Circulation|November 14, 1997
International Gargellen ConferenceG Hasenfuss, H Just
Therapeutische Umschau. Revue Therapeutique|June 22, 2000
[Pathophysiological basis of heart failure]B Pieske, G Hasenfuss
Pageof 16